Lin Xiaona, Shi Yongli, Yu ShaSha, Li Siyi, Li Wenhui, Li Meishuang, Chen Shengxi, Wang Yuanbo, Cong Mei
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
College of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Front Chem. 2020 Apr 15;8:212. doi: 10.3389/fchem.2020.00212. eCollection 2020.
A novel polymer of poloxamer188--PCL was synthesized via a ring-opening polymerization. Fourier transform infrared spectroscopy (FTIR), Raman, and H nuclear magnetic resonance (H NMR) spectra were used to study the structures of obtained poloxamer188--PCL. The thermo-stability of poloxamer188 --PCL was carried out with a thermal gravimetric analyzer (TGA), and cytotoxicity was obtained using the CCK8 method. Cargo-free and curcumin (CUR)-loaded poloxamer188--PCL NPs were fabricated via the solvent evaporation method. The morphology, particle size distribution, and stability of cargo-free NPs were studied with a scanning electron microscope (SEM) and laser particle analyzer. The radioprotection activity of CUR-loaded NPs was performed. FTIR, Raman, and H NMR spectra confirmed that poloxamer188--PCL was obtained. TGA curves suggested poloxamer188--PCL had better thermo-stability than original poloxamer188. Cell tests suggested that the cargo-free NPs had no cytotoxicity. SEM image showed that the cargo-free NPs were spherical with a diameter of 100 nm. Free radical scavenging experiments proved that CUR-loaded NPs had better antioxidant activity than CUR solutions. CUR-loaded NPs could be detected in all tissues, including liver, kidneys and lung. In summary, this work demonstrated a feasibility of developing an injective formulation of CUR and provided a protection agent in caner radiotherapy.
通过开环聚合法合成了一种新型的泊洛沙姆188-聚己内酯聚合物。利用傅里叶变换红外光谱(FTIR)、拉曼光谱和氢核磁共振(H NMR)光谱研究了所得泊洛沙姆188-聚己内酯的结构。用热重分析仪(TGA)对泊洛沙姆188-聚己内酯的热稳定性进行了研究,并采用CCK8法测定了其细胞毒性。通过溶剂蒸发法制备了无载药和载姜黄素(CUR)的泊洛沙姆188-聚己内酯纳米粒。用扫描电子显微镜(SEM)和激光粒度分析仪研究了无载药纳米粒的形态、粒径分布和稳定性。对载CUR纳米粒的辐射防护活性进行了检测。FTIR、拉曼光谱和H NMR光谱证实合成了泊洛沙姆188-聚己内酯。TGA曲线表明泊洛沙姆188-聚己内酯比原始泊洛沙姆188具有更好的热稳定性。细胞试验表明无载药纳米粒无细胞毒性。SEM图像显示无载药纳米粒呈球形,直径为100nm。自由基清除实验证明载CUR纳米粒比CUR溶液具有更好的抗氧化活性。在包括肝脏、肾脏和肺在内的所有组织中都能检测到载CUR纳米粒。总之,这项工作证明了开发CUR注射剂的可行性,并为癌症放疗提供了一种保护剂。